| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |